154 related articles for article (PubMed ID: 36348021)
21. Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas.
Skiriute D; Tamasauskas S; Asmoniene V; Saferis V; Skauminas K; Deltuva V; Tamasauskas A
J Neurooncol; 2011 Mar; 102(1):89-94. PubMed ID: 20607352
[TBL] [Abstract][Full Text] [Related]
22. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
23. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
24. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas.
Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361
[TBL] [Abstract][Full Text] [Related]
26. De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.
Peyre M; Gauchotte G; Giry M; Froehlich S; Pallud J; Graillon T; Bielle F; Cazals-Hatem D; Varlet P; Figarella-Branger D; Loiseau H; Kalamarides M
Neuro Oncol; 2018 Jul; 20(8):1113-1121. PubMed ID: 29216385
[TBL] [Abstract][Full Text] [Related]
27. Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a "Grade Zero" Resection.
Mooney MA; Abolfotoh M; Bi WL; Tavanaiepour D; Almefty RO; Bassiouni H; Pravdenkova S; Dunn IF; Al-Mefty O
Neurosurgery; 2020 Oct; 87(5):900-909. PubMed ID: 32294205
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
[TBL] [Abstract][Full Text] [Related]
29. Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study.
Garcia-Segura ME; Erickson AW; Jairath R; Munoz DG; Das S
Neurosurgery; 2020 Dec; 88(1):E42-E48. PubMed ID: 32818240
[TBL] [Abstract][Full Text] [Related]
30. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
Sá-Marta E; Alves JL; Rebelo O; Barbosa M
World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
[TBL] [Abstract][Full Text] [Related]
31. Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.
Guyot A; Duchesne M; Robert S; Lia AS; Derouault P; Scaon E; Lemnos L; Salle H; Durand K; Labrousse F
J Neurooncol; 2019 Dec; 145(3):449-459. PubMed ID: 31729637
[TBL] [Abstract][Full Text] [Related]
32. Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection.
Loewenstern J; Shuman W; Rutland JW; Kessler RA; Kohli KM; Umphlett M; Pain M; Bederson J; Fowkes M; Shrivastava RK
World Neurosurg; 2019 Aug; 128():e148-e156. PubMed ID: 30995555
[TBL] [Abstract][Full Text] [Related]
33. Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk.
Hua L; Ren L; Wu Q; Deng J; Chen J; Cheng H; Wang D; Chen H; Xie Q; Wakimoto H; Gong Y
J Neurooncol; 2023 Jan; 161(2):267-275. PubMed ID: 36329368
[TBL] [Abstract][Full Text] [Related]
34. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
Ho DM; Hsu CY; Ting LT; Chiang H
Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
[TBL] [Abstract][Full Text] [Related]
35. Molecular biological determinations of meningioma progression and recurrence.
Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
[TBL] [Abstract][Full Text] [Related]
36. Dramatic radiographic response resulting in cerebrospinal fluid rhinorrhea associated with sunitinib therapy in recurrent atypical meningioma: case report.
Raheja A; Colman H; Palmer CA; Couldwell WT
J Neurosurg; 2017 Nov; 127(5):965-970. PubMed ID: 27935362
[TBL] [Abstract][Full Text] [Related]
37. Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.
Schmidt M; Mock A; Jungk C; Sahm F; Ull AT; Warta R; Lamszus K; Gousias K; Ketter R; Roesch S; Rapp C; Schefzyk S; Urbschat S; Lahrmann B; Kessler AF; Löhr M; Senft C; Grabe N; Reuss D; Beckhove P; Westphal M; von Deimling A; Unterberg A; Simon M; Herold-Mende C
Oncotarget; 2016 Mar; 7(12):14551-68. PubMed ID: 26894859
[TBL] [Abstract][Full Text] [Related]
38. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
[TBL] [Abstract][Full Text] [Related]
39. Radical treatment strategies improve the long-term outcome of recurrent atypical meningiomas.
Li F; Lai ZP; Lin JK; Zhu G; Feng H
Chin Med J (Engl); 2011 Aug; 124(15):2387-91. PubMed ID: 22029080
[TBL] [Abstract][Full Text] [Related]
40. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
